With the advent of PSMA-targeted diagnostic and therapeutic treatments, this comprehensive data provide a scaffold for the rationale to investigate PSMA-targeted diagnostic and therapeutic strategies in RCC. The gene discussed is FOLH1; the disease is renal cell carcinoma.